3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
2
Phase NA
1
Phase 1/2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Prostatic Neoplasms
13
Head and Neck Neoplasms
8
Breast Neoplasms
8
Nasopharyngeal Carcinoma
6
Uterine Cervical Neoplasms
5
Neoplasm Metastasis
5
Squamous Cell Carcinoma of Head and Neck
4
Oropharyngeal Neoplasms
4
Neoplasms
4
Brain Neoplasms
4
Urinary Bladder Neoplasms
3
Radiation Injuries
3
Glioma
3
Carcinoma, Squamous Cell
3
Sarcoma, Ewing
2
Sarcoma
2
Rectal Neoplasms
2
Nasopharyngeal Neoplasms
2
Mesothelioma, Malignant
2
Meningeal Carcinomatosis
2
Glioblastoma
2
Wilms Tumor
1
Virus Diseases
1
Tumor Virus Infections
1
Tongue Neoplasms
1
Thyroid Neoplasms
1
Stage IA Uterine Sarcoma
1
Sinonasal undifferentiated carcinoma
1
Salivary Gland Neoplasms
1
Rhabdomyosarcoma
1
Interventions
Radiosurgery
7
lenvatinib
5
Radiofrequency Ablation
5
Electroporation
5
Radiotherapy
3
Patient Navigation
3
Laparoscopy
3
Hepatectomy
3
Exercise
3
sintilimab
2
perflutren
2
Surgical Procedures, Operative
2
Standard of Care
2
Proton Therapy
2
Nutritional Status
2
Magnetic Resonance Spectroscopy
2
Liver Transplantation
2
Injections
2
Dextrins
2
Cryosurgery
2
Control Groups
2
Bupivacaine
2
Anesthesia, General
2
toripalimab
1
tislelizumab
1
seocalcitol
1
pembrolizumab
1
motexafin gadolinium
1
gadofosveset trisodium
1
gadobutrol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Liver Neoplasms
×
Radiotherapy, Intensity-Modulated
×
Clear all
NCT05339581
2022-04-27
iPLENTY-pvtt
RenJi Hospital
Phase NA
Unknown
78 enrolled